Congenital cardiac malformation is the most frequent birth defect and it contributes to advanced heart failure in the pediatric and adult population. An enhanced understanding of the transcriptional networks that direct cardiac progenitors during heart development will have important applications related to cell based therapies and the treatment of congenital heart disease. Furthermore, a number of parallel transcriptional pathways or networks have been proposed for the generation and regeneration of tissues such as the heart. For these reasons, we predict that the definition of the transcriptional regulatory mechanisms of cardiac progenitor cells in the developing heart will enhance our understanding of cardiogenesis, congenital heart disease and myocardial regeneration. We have recently utilized transgenic technology to isolate and characterize cardiac progenitor cells from the developing mouse heart. We have identified Etsrp71 as a potential downstream target of Nkx2-5 and generated Etsrp71 deficient embryos that are nonviable and have perturbed cardiovascular development. Our principle hypothesis is that Nkx2-5 regulated networks direct discrete stages of cardiac morphogenesis. We further predict that the Etsrp71 is a direct downstream target of Nkx2-5 and is a master regulator of the endocardial/endothelial lineages. In these proposed studies, we take an innovative approach to examine these hypotheses and employ emerging technologies to define the role of the Nkx2-5 - Etsrp71 cascade and cardiovascular development. To examine these hypotheses, we will address the following specific aims: 1) To define the Nkx2.5 transcriptional regulatory cascades in cardiac progenitor cells isolated from the developing murine heart. 2) To define the functional role of Etsrp71 during embryogenesis. 3) To determine whether Etsrp71 is a master regulator of the endocardial/endothelial lineage. These studies will enhance our understanding of the role of transcriptional networks and signaling pathways that mechanistically regulate cardiac progenitor cell (CPC) populations to acquire a cardiovascular fate during development. In addition, the results of these studies will serve as a platform for therapeutic strategies directed towards congenital heart disease and advanced heart failure.

Public Health Relevance

Congenital heart disease is common and deadly. An increased understanding of the networks that direct cardiac progenitors and stem cells during heart development will have important therapeutic applications for the treatment of congenital heart disease. As the regulation of these progenitor cells are largely unknown, this proposal will decipher the molecular pathways that govern cardiac progenitors, which may ultimately serve as a platform to enhance the regenerative process in patients with cardiac malformations and advanced heart failure.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL085729-02
Application #
7851358
Study Section
Cardiovascular Differentiation and Development Study Section (CDD)
Program Officer
Schramm, Charlene A
Project Start
2009-07-01
Project End
2013-06-30
Budget Start
2010-07-01
Budget End
2013-06-30
Support Year
2
Fiscal Year
2010
Total Cost
$488,127
Indirect Cost
Name
University of Minnesota Twin Cities
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
555917996
City
Minneapolis
State
MN
Country
United States
Zip Code
55455
Shi, Xiaozhong; Richard, Jai; Zirbes, Katie M et al. (2014) Cooperative interaction of Etv2 and Gata2 regulates the development of endothelial and hematopoietic lineages. Dev Biol 389:208-18
Rasmussen, Tara L; Martin, Cindy M; Walter, Camille A et al. (2013) Etv2 rescues Flk1 mutant embryoid bodies. Genesis 51:471-80
Borges, Luciene; Iacovino, Michelina; Mayerhofer, Timothy et al. (2012) A critical role for endoglin in the emergence of blood during embryonic development. Blood 119:5417-28
Koyano-Nakagawa, Naoko; Kweon, Junghun; Iacovino, Michelina et al. (2012) Etv2 is expressed in the yolk sac hematopoietic and endothelial progenitors and regulates Lmo2 gene expression. Stem Cells 30:1611-23
Rasmussen, Tara L; Shi, Xiaozhong; Wallis, Alicia et al. (2012) VEGF/Flk1 signaling cascade transactivates Etv2 gene expression. PLoS One 7:e50103
Rasmussen, Tara L; Kweon, Junghun; Diekmann, Mackenzie A et al. (2011) ER71 directs mesodermal fate decisions during embryogenesis. Development 138:4801-12
Caprioli, Arianna; Koyano-Nakagawa, Naoko; Iacovino, Michelina et al. (2011) Nkx2-5 represses Gata1 gene expression and modulates the cellular fate of cardiac progenitors during embryogenesis. Circulation 123:1633-41
Rasmussen, Tara L; Raveendran, Ganesh; Zhang, Jianyi et al. (2011) Getting to the heart of myocardial stem cells and cell therapy. Circulation 123:1771-9
Sadek, Hesham A; Martin, Cindy M; Latif, Shuaib S et al. (2009) Bone-marrow-derived side population cells for myocardial regeneration. J Cardiovasc Transl Res 2:173-81